Deliver Your News to the World

Recombinant C-Reactive Protein


WEBWIRE

St. Louis, MO. Lee Biosolutions has announced that it will increase its C-Reactive Protein product line to include recombinant C-Reactive Protein.

C-Reactive Protein is a protein found in the blood that operates as a marker for inflammation, meaning its presence indicates an increased state of inflammation in the body. Inflammation is a normal response to a number of physical states including injury, fever and infection. Inflammation is also believed to play a role in the initiation and progression of cardiovascular disease.

r-hCRP is produced into culture medium by DNA recombinant procedure in E. Coli as secretory protein. By expressing kil gene, the outer membrane of E. Coli becomes permeable, allowing recombinant C-Reactive Protein to be excreted without cell lysis. r-hCRP has similar biological property in terms of Ca2+-binding ability to the native protein, and is purified by affinity chromatography. N-terminal amino acid sequence of r-hCRP is the same as that of the native human c-reactive protein

According to Lee Biosolutions President Burton Lee, the company pays close attention to the clinical research community to stay ahead of their demands for acute phase proteins like C-Reactive Protein CRP . Lee Biosolution now has canine, rat, human and recombinant c-reactive protein.


Burton Lee
President
Lee Biosolutions, Inc
2924 Mary Ave
St. Louis, MO 63144
www.leebio.com



WebWireID94496




 
 recombinant , antigen
 c-reactive protein,crp
 research , laboratory
 human enzyme
 diagnostic, clinical


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.